Pediatric Perfusion Products Market - Top Companies and Manufacturers

  • Report ID: 2686
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Pediatric Perfusion Products Landscape

    • Medtronic 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Fluigent
    • Masimo
    • Terumo Cardiovascular Systems
    • LivaNova PLC
    • Eurosets
    • General Electric Company
    • Nonin
    • Getinge AB
    • Koninklijke Philips N.V.
    • BL Lifesciences.

     


Browse Key Market Insights with Data Illustration:

In the News

  •  January 3, 2020 – Masimo’s RD Set Sensors got clearance from the FDA. It features the company’s signature Measure-through Motion and Low Perfusion SET pulse oximetry, to exhibit much better accuracy while observing neonatal patients.

  • Perfusion Week 2020 – American Society of Extracorporeal Technology organizes PERFUSION WEEK every year to recognize the dedication of perfusionists around the world. This year April 27 marks the first day of Perfusion Week 2020.

  • February 27, 2020 – A team of researchers from Boston Children’s Hospital and Harvard developed an artificial valve that can be expanded and is comparatively cheaper to perform. Since various congenital surgeries require placement of prosthetic heart valves and as the heart grows with the infant’s age, valves have to be replaced through repeated surgeries which is altogether an expensive process.


Author Credits:  Radhika Pawar


  • Report ID: 2686
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pediatric perfusion products is evaluated at USD 198.87 million.

Pediatric Perfusion Products Market size was valued at USD 187.25 million in 2024 and is set to exceed USD 467.97 million by 2037, expanding at over 7.3% CAGR during the forecast period i.e., between 2025-2037.

North America industry is predicted to hold largest revenue share by 2037, on account of high prevalence of congenital heart diseases in the U.S., increase in diagnosis rate of congenital heart diseases, high open heart surgery rate, and well-established health care infrastructure.

The major players in the market are Medtronic, Fluigent, Masimo, Terumo Cardiovascular Systems, LivaNova PLC, Eurosets, General Electric Company, Nonin, Getinge AB, Koninklijke Philips N.V., BL Lifesciences., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample